explore -WSS

explore

author：focus 2025-10-02 22:58:33 - browse：1

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Beyond aggravation: Constipation is an American epidemic

entertainment

knowledge

WSS

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

New research sheds light on how often breast cancer is overdiagnosed

Lawsuit challenges CMS nursing home minimum staffing rule

New research sheds light on how often breast cancer is overdiagnosed

Medical students need to learn the potent medicine of empathy

J&J reports mixed data on next

Wikipedia

explore

Wikipedia

Bright Health sells Medicare Advantage business to Molina

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

United colonoscopy coverage change 'may cost lives,' doctors say

Should insurance cover cosmetic surgery?

Walensky prepares to leave CDC — and Congress — behind

The world needs the new pandemic treaty

Dobbs anniversary: the lost opportunity of abortion as health care

In rare move, senator releases unverified FBI source report alleging Biden bribe

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Unmasking the 'centricity' illusion in clinical trials

focus

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Scientists grapple with ethics of stem cell research

Protect nursing home residents from future pandemics

Clinicians often fail to acknowledge the pain caused by long Covid

5 dead in mass shooting on Caribbean island of St. Vincent: Police

entertainment

entertainment

knowledge

hotspot